Kurt Krapfenbauer

2.4k total citations · 1 hit paper
46 papers, 1.9k citations indexed

About

Kurt Krapfenbauer is a scholar working on Molecular Biology, Spectroscopy and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kurt Krapfenbauer has authored 46 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 10 papers in Spectroscopy and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kurt Krapfenbauer's work include Advanced Proteomics Techniques and Applications (9 papers), Mitochondrial Function and Pathology (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Kurt Krapfenbauer is often cited by papers focused on Advanced Proteomics Techniques and Applications (9 papers), Mitochondrial Function and Pathology (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Kurt Krapfenbauer collaborates with scholars based in Austria, Switzerland and United Kingdom. Kurt Krapfenbauer's co-authors include Gert Lübec, Michael Fountoulakis, Elisabeth Drucker, Nigel J. Cairns, Ephrem Engidawork, Dietmar Thurnher, Marko Kapalla, Olga Golubnitschaja, Vincenzo Costigliola and Rostyslav Bubnov and has published in prestigious journals such as Brain Research, Neuroscience and Progress in Neurobiology.

In The Last Decade

Kurt Krapfenbauer

46 papers receiving 1.8k citations

Hit Papers

Medicine in the early twenty-first century: paradigm and ... 2016 2026 2019 2022 2016 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Krapfenbauer Austria 19 1.1k 321 295 210 150 46 1.9k
Bruno Casetta Italy 24 818 0.8× 278 0.9× 167 0.6× 138 0.7× 176 1.2× 41 1.8k
Paul M. Stemmer United States 27 1.3k 1.2× 275 0.9× 137 0.5× 117 0.6× 226 1.5× 116 2.2k
Yoshiaki Sato Japan 25 656 0.6× 178 0.6× 319 1.1× 183 0.9× 69 0.5× 109 2.3k
Takako Hishiki Japan 30 1.4k 1.3× 147 0.5× 378 1.3× 170 0.8× 165 1.1× 57 2.4k
William P. Dubinsky United States 27 1.1k 1.1× 119 0.4× 364 1.2× 158 0.8× 164 1.1× 66 1.8k
Stephen G. Kaler United States 32 1.5k 1.4× 374 1.2× 404 1.4× 140 0.7× 374 2.5× 106 4.0k
Hedley C. Freake United States 24 1.0k 1.0× 502 1.6× 482 1.6× 203 1.0× 242 1.6× 59 2.7k
Danni Li China 26 1.1k 1.1× 266 0.8× 306 1.0× 212 1.0× 153 1.0× 127 2.2k
George Deliconstantinos Greece 25 748 0.7× 132 0.4× 411 1.4× 164 0.8× 164 1.1× 77 2.0k
Dong Hoon Kang South Korea 23 813 0.8× 292 0.9× 138 0.5× 115 0.5× 110 0.7× 90 1.8k

Countries citing papers authored by Kurt Krapfenbauer

Since Specialization
Citations

This map shows the geographic impact of Kurt Krapfenbauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Krapfenbauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Krapfenbauer more than expected).

Fields of papers citing papers by Kurt Krapfenbauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Krapfenbauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Krapfenbauer. The network helps show where Kurt Krapfenbauer may publish in the future.

Co-authorship network of co-authors of Kurt Krapfenbauer

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Krapfenbauer. A scholar is included among the top collaborators of Kurt Krapfenbauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Krapfenbauer. Kurt Krapfenbauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Golubnitschaja, Olga, Babak Baban, Giovanni Boniolo, et al.. (2016). Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016. The EPMA Journal. 7(1). 23–23. 287 indexed citations breakdown →
5.
Waerner, Thomas, Dietmar Thurnher, & Kurt Krapfenbauer. (2010). The role of laboratory medicine in healthcare: quality requirements of immunoassays, standardisation and data management in prospective medicine. The EPMA Journal. 1(4). 619–626. 11 indexed citations
6.
Krapfenbauer, Kurt & Michael Fountoulakis. (2009). Improved Enrichment and Proteomic Analysis of Brain Proteins with Signaling Function by Heparin Chromatography. Methods in molecular biology. 566. 165–180. 7 indexed citations
7.
Koehn, James A., M. Fountoulakis, & Kurt Krapfenbauer. (2008). Multiple Drug Resistance Associated with Function of ABC-Transporters in Diabetes Mellitus: Molecular Mechanism and Clinical Relevance. Infectious Disorders - Drug Targets. 8(2). 109–118. 18 indexed citations
8.
Turhani, Dritan, Kurt Krapfenbauer, Dietmar Thurnher, Hanno Langen, & Michael Fountoulakis. (2006). Identification of differentially expressed, tumor‐associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis. 27(7). 1417–1423. 117 indexed citations
9.
Shin, Joo‐Ho, Kurt Krapfenbauer, & Gert Lübec. (2005). Column chromatographic prefractionation leads to the detection of 543 different gene products in human fetal brain. Electrophoresis. 26(14). 2759–2778. 8 indexed citations
10.
Oh, Jieun, Kurt Krapfenbauer, & Gert Lübec. (2004). Proteomic identification of collagens and related proteins in human fibroblasts. Amino Acids. 27(3-4). 305–311. 6 indexed citations
11.
Afjehi‐Sadat, Leila, Kurt Krapfenbauer, Irene Slavc, Michael Fountoulakis, & Gert Lübec. (2004). Hypothetical proteins with putative enzyme activity in human amnion, lymphocyte, bronchial epithelial and kidney cell lines. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1700(1). 65–74. 4 indexed citations
12.
Krapfenbauer, Kurt, Michael Fountoulakis, & Gert Lübec. (2003). A rat brain protein expression map including cytosolic and enriched mitochondrial and microsomal fractions. Electrophoresis. 24(11). 1847–1870. 75 indexed citations
13.
Lübec, Gert, Kurt Krapfenbauer, & Michael Fountoulakis. (2003). Proteomics in brain research: potentials and limitations. Progress in Neurobiology. 69(3). 193–211. 131 indexed citations
14.
Krapfenbauer, Kurt, Ephrem Engidawork, Nigel J. Cairns, Michael Fountoulakis, & Gert Lübec. (2003). Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Research. 967(1-2). 152–160. 237 indexed citations
15.
Peyrl, Andreas, Kurt Krapfenbauer, Irene Slavc, et al.. (2003). Protein profiles of medulloblastoma cell lines DAOY and D283: Identification of tumor‐related proteins and principles. PROTEOMICS. 3(9). 1781–1800. 40 indexed citations
16.
Kim, Seong Hwan, Kurt Krapfenbauer, Myeong Sook Cheon, et al.. (2002). Human brain cytosolic histamine-N-methyltransferase is decreased in Down syndrome and increased in Pick's disease. Neuroscience Letters. 321(3). 169–172. 17 indexed citations
18.
Lubec, Barbara, Andrey V. Kozlov, Kurt Krapfenbauer, et al.. (1999). Nitric oxide and nitric oxide synthase in the early phase of perinatal asphyxia of the rat. Neuroscience. 93(3). 1017–1023. 17 indexed citations
19.
Krapfenbauer, Kurt, Byong Chul Yoo, Nigel J. Cairns, & Gert Lübec. (1999). Differential display reveals deteriorated mRNA levels of NADH3 (complex I) in cerebellum of patients with Down Syndrome. PubMed. 57. 211–220. 11 indexed citations
20.
Labudová, Olga, Kurt Krapfenbauer, H. Rink, et al.. (1998). Decreased transcription factor junD in brains of patients with Down syndrome. Neuroscience Letters. 252(3). 159–162. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026